...
首页> 外文期刊>Medicine. >High Body Mass Index Reduces Glomerular Filtration Rate Decline in Type II Diabetes Mellitus Patients With Stage 3 or 4 Chronic Kidney Disease
【24h】

High Body Mass Index Reduces Glomerular Filtration Rate Decline in Type II Diabetes Mellitus Patients With Stage 3 or 4 Chronic Kidney Disease

机译:高体重指数降低患有3期或4期慢性肾脏疾病的II型糖尿病患者的肾小球滤过率下降

获取原文

摘要

Abstract: Whether high body mass index (BMI) has an effect on progressive diabetic nephropathy in type II diabetes mellitus (DM) patients with chronic kidney disease (CKD) stage 3 or 4 remains unclear. This prospective study aimed to investigate the relationship between BMI and progression of renal function deterioration in type II DM patients with CKD stage 3 or 4. A total of 105 type II DM patients with CKD stage 3 or 4 participated in this 24-month prospective observational study. Patients were divided into 3 groups according to BMI as follows: normal group, BMI of 18.5–22.9?kg/m2; overweight group, BMI of 23–24.9?kg/m2; and obese group, BMI of ≥25?kg/m2. The primary end point was a 2-fold elevation in serum creatinine levels (measured twice with a 1-month interval) from baseline values, need for long-term dialysis, or death during the 24-month observation period. In the linear regression analysis with the stepwise method, each 1?kg/m2 increase in BMI led to an increase of 0.32?mL?min?1?×?1.73?m?2 in the estimated glomerular filtration rate (95% confidence interval, CI, 0.01–0.62; P?=?0.04) during the 24-month study period. Moreover, multivariate Cox regression analysis showed that compared with the obese group, the normal BMI group (hazard ratio?=?2.76, 95% CI?:?1.27–6; P?=?0.01) achieved the primary outcome after adjusting for other factors. In this 24-month prospective observational study, we showed that BMI of ≥25?kg/m2 was a protective factor for renal function deterioration in type II DM patients with CKD stage 3 or 4.
机译:摘要:高体重指数(BMI)是否对患有慢性肾脏病(CKD)3或4期的II型糖尿病(DM)患者进行性糖尿病肾病有影响,目前尚不清楚。这项前瞻性研究旨在探讨CKD 3或4期II型DM患者的BMI与肾功能恶化进展之间的关系。共有105名CKD 3或4期II型DM患者参加了这一为期24个月的前瞻性观察研究。根据BMI将患者分为3组:正常组,BMI为18.5-22.9?kg / m 2 ;超重组,BMI为23–24.9?kg / m 2 ;肥胖组的BMI≥25?kg / m 2 。主要终点是血清肌酐水平较基线水平升高2倍(以1个月为间隔两次测量),需要长期透析或在24个月观察期内死亡。在逐步方法的线性回归分析中,BMI每增加1?kg / m 2 ,导致BMI增加0.32?mL?min ?1 ?×?1.73在24个月的研究期间,估计的肾小球滤过率(95%置信区间,CI,0.01-0.62; P?=?0.04)中的?m ?2 。此外,多因素Cox回归分析显示,与肥胖组相比,正常BMI组(危险比?=?2.76,95%CI?:?1.27-6; P?=?0.01)在调整其他因素后达到了主要结果。因素。在这项为期24个月的前瞻性观察研究中,我们显示BMI≥25?kg / m 2 是CKD 3或4期II型DM患者肾功能恶化的保护因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号